
Pregabalin (75mg) + Nortriptyline (10mg)
Active composition
+1 more active ingredient
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their levels in the synaptic cleft and enhancing mood.
Medical applications
Notritek-P Tablet SR is a combined pharmaceutical formulation, containing 75mg of Pregabalin and 10mg of Nortriptyline. This extended-release tablet is designed for twice-daily administration. Pregabalin, an antiepileptic and analgesic, is used primarily for the management of neuropathic pain and epilepsy, while Nortriptyline, a tricyclic antidepressant, is indicated for major depressive disorders. The combination of these two active ingredients aims to provide comprehensive relief for certain neuropathic pain conditions and associated depression. As with all medications, it is essential to adhere to the prescribed dosage and consult a healthcare provider for proper usage and potential interactions with other drugs or health conditions.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Notritek-P Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Notritek-P Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Notritek-P Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Notritek-P Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Notritek-P Tablet SR may cause side effects which could affect your ability to drive. As Notritek-P Tablet SR may affect your alertness which may affect your ability to drive.
Consult Doctor
Notritek-P Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Notritek-P Tablet SR may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Notritek-P Tablet SR

Pregabalin (75mg) + Nortriptyline (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their levels in the synaptic cleft and enhancing mood.
Medical applications
Notritek-P Tablet SR is a combined pharmaceutical formulation, containing 75mg of Pregabalin and 10mg of Nortriptyline. This extended-release tablet is designed for twice-daily administration. Pregabalin, an antiepileptic and analgesic, is used primarily for the management of neuropathic pain and epilepsy, while Nortriptyline, a tricyclic antidepressant, is indicated for major depressive disorders. The combination of these two active ingredients aims to provide comprehensive relief for certain neuropathic pain conditions and associated depression. As with all medications, it is essential to adhere to the prescribed dosage and consult a healthcare provider for proper usage and potential interactions with other drugs or health conditions.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Notritek-P Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Notritek-P Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Notritek-P Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Notritek-P Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Notritek-P Tablet SR may cause side effects which could affect your ability to drive. As Notritek-P Tablet SR may affect your alertness which may affect your ability to drive.
Consult Doctor
Notritek-P Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Notritek-P Tablet SR may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Notritek-P Tablet SR















